This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
Histone H3 (acetyl K56) monoclonal antibody, clone RM179
catalog :
MAB12782
quantity :
100 ug
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
western blot, ELISA, immunocytochemistry, immunohistochemistry - paraffin section
product information
catalog id :
MAB12782
product name :
Histone H3 (acetyl K56) monoclonal antibody, clone RM179
product description :
Rabbit monoclonal antibody raised against synthetic acetyl peptide of human Histone H3 (acetyl K56).
clone name :
RM179
isotype :
IgG
gene name :
HIST1H3A
gene alias :
H3/A H3FA
gene description :
histone cluster 1, H3a
immunogen :
A synthetic acetyl peptide corresponding to residues surrounding K56 of Histone H3.
protein accession :
P84243
form :
Liquid
recommend dilutions :
ELISA (0.5 ug/mL-1 ug/mL). Immunocytochemistry (0.5 ug/mL-2 ug/mL). Immunohistochemistry (1 ug/mL-10 ug/mL). Western Blot (1 ug/mL-2 ug/mL). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS (50% glycerol, 1% BSA, 0.09% sodium azide)
storage instruction :
Store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Rabbit
antigen species target species :
Human
specificity :
This antibody reacts to Histone H3 acetylated at Lysine 56. No cross reactivity with other acetylated Lysines in histone H3.
application key :
WB,ELISA,ICC,IHC-P
size :
100 ug
autodate :
2016-01-29
updatetime :
2016-01-29 09:45:41
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments